Private Equity
Meritech raising a fifth fund; Khosla targeting $1 billion; and BlueRun seeks $150 million
7 min read · 01 July 2014
The company raised nearly $275 million from investors, which together saw a 3.43x return at the time of the IPO
1 min read · 01 July 2014
The company, which produces wearable high definition cameras and accessories, was valued at just over $3 billion following the offering
3 min read · 01 July 2014
Investors, including General Catalyst Partners, Highland Capital Partners and Polaris Partners, put about $50 million into the company and saw a return of 6.09x at the time of the IPO
1 min read · 01 July 2014
The company’s post-offering value was $240 million following its IPO, which was priced at $17 a share
1 min read · 01 July 2014
Foundation Capital, Norwest Venture Partners, Sequoia Capital and Storm Ventures saw a total return of 3.23x on their $160 million investment
1 min read · 01 July 2014
The drug developer raised more than $213 million in funding prior to its IPO
1 min read · 01 July 2014
Alta, Atlas, Greatpoint Ventures, RA Capital Management and Third Rock Ventures invested nearly $160 million in the company, which is developing a treatment for obesity
1 min read · 01 July 2014
Investors, including RiverVest, Alta, Novo A/S and others, saw a 3.19x return on their $96 million investemnt
1 min read · 01 July 2014
Investors, including Amgen, CMEA and NEA, invested $56 million in the drug developer that focuses on the gastrointestinal tract
1 min read · 01 July 2014
